379 related articles for article (PubMed ID: 28486019)
1. Role of Bone Marrow Mononuclear Cell Seeding for Nanofiber Vascular Grafts.
Fukunishi T; Best CA; Ong CS; Groehl T; Reinhardt J; Yi T; Miyachi H; Zhang H; Shinoka T; Breuer CK; Johnson J; Hibino N
Tissue Eng Part A; 2018 Jan; 24(1-2):135-144. PubMed ID: 28486019
[TBL] [Abstract][Full Text] [Related]
2. Bone marrow-derived mononuclear cell seeded bioresorbable vascular graft improves acute graft patency by inhibiting thrombus formation via platelet adhesion.
Miyachi H; Reinhardt JW; Otsuru S; Tara S; Nakayama H; Yi T; Lee YU; Miyamoto S; Shoji T; Sugiura T; Breuer CK; Shinoka T
Int J Cardiol; 2018 Sep; 266():61-66. PubMed ID: 29887474
[TBL] [Abstract][Full Text] [Related]
3. Comparison of human bone marrow mononuclear cell isolation methods for creating tissue-engineered vascular grafts: novel filter system versus traditional density centrifugation method.
Hibino N; Nalbandian A; Devine L; Martinez RS; McGillicuddy E; Yi T; Karandish S; Ortolano GA; Shin'oka T; Snyder E; Breuer CK
Tissue Eng Part C Methods; 2011 Oct; 17(10):993-8. PubMed ID: 21609305
[TBL] [Abstract][Full Text] [Related]
4. Deconstructing the Tissue Engineered Vascular Graft: Evaluating Scaffold Pre-Wetting, Conditioned Media Incubation, and Determining the Optimal Mononuclear Cell Source.
Best C; Tara S; Wiet M; Reinhardt J; Pepper V; Ball M; Yi T; Shinoka T; Breuer C
ACS Biomater Sci Eng; 2017; 3(9):1972-1979. PubMed ID: 29226239
[TBL] [Abstract][Full Text] [Related]
5. Comparison of the biological equivalence of two methods for isolating bone marrow mononuclear cells for fabricating tissue-engineered vascular grafts.
Kurobe H; Tara S; Maxfield MW; Rocco KA; Bagi PS; Yi T; Udelsman BV; Dean EW; Khosravi R; Powell HM; Shinoka T; Breuer CK
Tissue Eng Part C Methods; 2015 Jun; 21(6):597-604. PubMed ID: 25397868
[TBL] [Abstract][Full Text] [Related]
6. Preclinical study of patient-specific cell-free nanofiber tissue-engineered vascular grafts using 3-dimensional printing in a sheep model.
Fukunishi T; Best CA; Sugiura T; Opfermann J; Ong CS; Shinoka T; Breuer CK; Krieger A; Johnson J; Hibino N
J Thorac Cardiovasc Surg; 2017 Apr; 153(4):924-932. PubMed ID: 27938900
[TBL] [Abstract][Full Text] [Related]
7. Tissue-engineered vascular grafts: does cell seeding matter?
Mirensky TL; Hibino N; Sawh-Martinez RF; Yi T; Villalona G; Shinoka T; Breuer CK
J Pediatr Surg; 2010 Jun; 45(6):1299-305. PubMed ID: 20620335
[TBL] [Abstract][Full Text] [Related]
8. Construction of an autologous tissue-engineered venous conduit from bone marrow-derived vascular cells: optimization of cell harvest and seeding techniques.
Roh JD; Brennan MP; Lopez-Soler RI; Fong PM; Goyal A; Dardik A; Breuer CK
J Pediatr Surg; 2007 Jan; 42(1):198-202. PubMed ID: 17208565
[TBL] [Abstract][Full Text] [Related]
9. Tissue-Engineered Small Diameter Arterial Vascular Grafts from Cell-Free Nanofiber PCL/Chitosan Scaffolds in a Sheep Model.
Fukunishi T; Best CA; Sugiura T; Shoji T; Yi T; Udelsman B; Ohst D; Ong CS; Zhang H; Shinoka T; Breuer CK; Johnson J; Hibino N
PLoS One; 2016; 11(7):e0158555. PubMed ID: 27467821
[TBL] [Abstract][Full Text] [Related]
10. Implantation of inferior vena cava interposition graft in mouse model.
Lee YU; Yi T; Tara S; Lee AY; Hibino N; Shinoka T; Breuer CK
J Vis Exp; 2014 Jun; (88):. PubMed ID: 24961688
[TBL] [Abstract][Full Text] [Related]
11. Evaluation of the use of an induced puripotent stem cell sheet for the construction of tissue-engineered vascular grafts.
Hibino N; Duncan DR; Nalbandian A; Yi T; Qyang Y; Shinoka T; Breuer CK
J Thorac Cardiovasc Surg; 2012 Mar; 143(3):696-703. PubMed ID: 22244569
[TBL] [Abstract][Full Text] [Related]
12. Rational design of an improved tissue-engineered vascular graft: determining the optimal cell dose and incubation time.
Lee YU; Mahler N; Best CA; Tara S; Sugiura T; Lee AY; Yi T; Hibino N; Shinoka T; Breuer C
Regen Med; 2016 Mar; 11(2):159-67. PubMed ID: 26925512
[TBL] [Abstract][Full Text] [Related]
13. Deconstructing tissue engineered trachea: Assessing the role of synthetic scaffolds, segmental replacement and cell seeding on graft performance.
Dharmadhikari S; Liu L; Shontz K; Wiet M; White A; Goins A; Akula H; Johnson J; Reynolds SD; Breuer CK; Chiang T
Acta Biomater; 2020 Jan; 102():181-191. PubMed ID: 31707085
[TBL] [Abstract][Full Text] [Related]
14. Effect of cell seeding on neotissue formation in a tissue engineered trachea.
Clark ES; Best C; Onwuka E; Sugiura T; Mahler N; Bolon B; Niehaus A; James I; Hibino N; Shinoka T; Johnson J; Breuer CK
J Pediatr Surg; 2016 Jan; 51(1):49-55. PubMed ID: 26552897
[TBL] [Abstract][Full Text] [Related]
15. TGF-β receptor 1 inhibition prevents stenosis of tissue-engineered vascular grafts by reducing host mononuclear phagocyte activation.
Lee YU; de Dios Ruiz-Rosado J; Mahler N; Best CA; Tara S; Yi T; Shoji T; Sugiura T; Lee AY; Robledo-Avila F; Hibino N; Pober JS; Shinoka T; Partida-Sanchez S; Breuer CK
FASEB J; 2016 Jul; 30(7):2627-36. PubMed ID: 27059717
[TBL] [Abstract][Full Text] [Related]
16. Preliminary experience with tissue engineering of a venous vascular patch by using bone marrow-derived cells and a hybrid biodegradable polymer scaffold.
Cho SW; Jeon O; Lim JE; Gwak SJ; Kim SS; Choi CY; Kim DI; Kim BS
J Vasc Surg; 2006 Dec; 44(6):1329-40. PubMed ID: 17145438
[TBL] [Abstract][Full Text] [Related]
17. Tissue-engineered blood vessel graft produced by self-derived cells and allogenic acellular matrix: a functional performance and histologic study.
Yang D; Guo T; Nie C; Morris SF
Ann Plast Surg; 2009 Mar; 62(3):297-303. PubMed ID: 19240529
[TBL] [Abstract][Full Text] [Related]
18. Pericyte-based human tissue engineered vascular grafts.
He W; Nieponice A; Soletti L; Hong Y; Gharaibeh B; Crisan M; Usas A; Peault B; Huard J; Wagner WR; Vorp DA
Biomaterials; 2010 Nov; 31(32):8235-44. PubMed ID: 20684982
[TBL] [Abstract][Full Text] [Related]
19. Evaluation of remodeling process in small-diameter cell-free tissue-engineered arterial graft.
Tara S; Kurobe H; Maxfield MW; Rocco KA; Yi T; Naito Y; Breuer CK; Shinoka T
J Vasc Surg; 2015 Sep; 62(3):734-43. PubMed ID: 24745941
[TBL] [Abstract][Full Text] [Related]
20. Development and in vivo evaluation of small-diameter vascular grafts engineered by outgrowth endothelial cells and electrospun chitosan/poly(ε-caprolactone) nanofibrous scaffolds.
Zhou M; Qiao W; Liu Z; Shang T; Qiao T; Mao C; Liu C
Tissue Eng Part A; 2014 Jan; 20(1-2):79-91. PubMed ID: 23902162
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
